Write your message
Volume 7, Issue 1 (Winter 2022)                   J Obstet Gynecol Cancer Res 2022, 7(1): 59-62 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ashrafganjoei T, Talayeh M, Noei Teymoordash S, Hashemi Bahremani M, talayeh H. Uterine Adenosarcoma: A Case Report and Review of Literature. J Obstet Gynecol Cancer Res. 2022; 7 (1) :59-62
URL: http://jogcr.com/article-1-369-en.html
1- Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , m_talayeh@yahoo.com
3- Department of Pathology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Velayat Medical Center, Qazvin University of Medical Science, Qazvin, Iran
Abstract:   (131 Views)
Uterine adenosarcoma (UA) is an infrequent malignancy which contains the epithelium of benign glands and malignant mesenchymal elements. Low-grade adenosarcoma has a sarcomatous part that is uniformly low grade. Uterine adenosarcoma includes 8% of all uterine sarcomas and less than 0.2% of uterine neoplasms. It is more common in perimenopausal or postmenopausal women. Due to the rarity of uterine adenosarcoma, limited information is available to help guide treatment.
A 33-year-old woman, who had one child referred to ????  with a complaint of abnormal uterine bleeding for one year; the sonography reported a polyp in fundal cavity of uterus. The patient underwent hysteroscopy and curettage. The pathology examination revealed uterine adenosarcoma which led to a total hysterectomy and bilateral salpingo-oophorectomy.
Abnormal uterine bleeding is the most common symptom of UA. At a young age there is a possibility of misdiagnosis. Hysteroscopy should also be performed if symptomatic or enlarge polypoid lesions are diagnosed preoperatively.
Full-Text [PDF 525 kb]   (8 Downloads) |   |   Full-Text (HTML)  (4 Views)  
Systematic Review: Case Report | Subject: Gynecology Oncology
Received: 2021/04/21 | Accepted: 2021/05/27 | Published: 2021/09/9

References
1. Yuan Z, Shen K, Yang J, Cao D, Zhang Y, Zhou H, et al. Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study. Front Oncol. 2019;14(9): 237. [DOI:10.3389/fonc.2019.00237] [PMID] [PMCID]
2. Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol. 1990;21(4):363-81. [DOI:10.1016/0046-8177(90)90198-E]
3. Ulrich U, A, Denschlag D. Uterine Adenosarcoma. Oncol Res Treat. 2018; 41:693-6. [DOI:10.1159/000494067] [PMID]
4. Zaloudek CJ, Hendrickson MR, Soslow RA. Mesenchymal tumors of the uterus; in Kurman RJ, Hedrick Ellenson L, Ronnet BM (eds). Blaustein's Pathology of the Female Genital Tract, ed 6. New York, Springer,2011. [DOI:10.1007/978-1-4419-0489-8_10]
5. Hodgson A, Amemiya Y, Seth A, Djordjevic B, Parra-Herran C. High-grade Müllerian adenosarcoma. Am J Surg Pathol. 2017;41(11):1513-22. [DOI:10.1097/PAS.0000000000000907] [PMID]
6. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine adenosarcoma: a review. Curr Oncol Rep. 2016; 18:68. [DOI:10.1007/s11912-016-0552-7] [PMID]
7. Fleming NA, Hopkins L, de Nanassy J, Senterman M, Black AY. Mullerian adenosarcoma of the cervix in a 10-year-old girl: case report and review of the literature. J Pediatr Adolesc Gynecol. 2009;22(4): e45-51. [DOI:10.1016/j.jpag.2008.06.001] [PMID]
8. Liu H, Shen Z, Wu D, Zhou Y. Uterine adenosarcoma with sarcomatous overgrowth: a case report of aggressive disease in a 16-year-old girl and a literature review. J Pediatr Adolesc Gynecol. 2018;31(4):426-31. [DOI:10.1016/j.jpag.2017.12.012] [PMID]
9. van Staalduinen B, Stahler A, Abied C, Shats R, Lakhi NA. Oncogenic potential and clinical implications of giant endometrial polyps: a case report and literature review. Case Rep Obstet Gynecol. 2018; 2018:1-6. [DOI:10.1155/2018/8753463] [PMID] [PMCID]
10. Wang JH, Zhao J, Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. Minim Invasive Gynecol. 2010; 17:53-8. [DOI:10.1016/j.jmig.2009.10.012] [PMID]
11. Elfayomy AK, Soliman BS. Risk factors associated with the malignant changes of symptomatic and asymptomatic endometrial polyps in premenopausal women. Obstet Gynaecol India. 2015; 65:186-92. [DOI:10.1007/s13224-014-0576-6] [PMID] [PMCID]
12. Taga S, Sawada M, Nagai A, Yamamoto D, Hayase R. A Case of Adenosarcoma of the Uterus. Case Rep Obstet Gynecol. 2014;2014. [DOI:10.1155/2014/342187] [PMID] [PMCID]
13. Tanner EJ, Toussaint T, Leitao Jr MM, Hensley ML, Soslow RA, Gardner GJ, et al. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecologic oncology. 2013;129(1):140-4. [DOI:10.1016/j.ygyno.2012.12.036] [PMID]
14. Shahidsales S, Farazestanian M, Sharifi‐Sistani N, Rasta S, Javadinia SA. TThe Uterine Adenosarcoma in a Young Woman Treated by TAH/BOS and Combined Adjuvant Therapy: A Case Report. Acta Medica Iranica. 2020:138-41. [DOI:10.18502/acta.v58i3.3779]
15. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine adenosarcoma: a review. Curr Oncol Rep. 2016;18(11):1-7. [DOI:10.1080/14737140.2018.1518136] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.